Komersantas, UAB - financials and debts

Company age: 6 y. 8 mo.

Update

Komersantas - Company finances

EUR
2020
From: 2020-02-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 16,117 82,451 88,947 54,479 19,269 80,653
Profit before tax 5,490 25,955 19,542 -2,096 2,621 4,412
Net profit 5,210 21,928 18,485 -2,112 2,573 4,070
Equity 7,710 29,638 48,123 46,010 48,583 52,653
Liabilities 1,852 26,687 31,292 19,862 19,237 42,202
Non-current assets 0 0 3,428 2,449 2,835 1,388
Current assets 9,734 56,622 75,886 63,282 64,990 93,467
Total assets 9,734 56,622 79,314 65,731 67,825 94,855
Taxes paid
STI taxes - - - - 504 133
Financial indicators
Revenue change y/y - +411.6% +7.9% -38.8% -64.6% +318.6%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 53.5% 38.7% 23.3% -3.2% 3.8% 4.3%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 67.6% 74.0% 38.4% -4.6% 5.3% 7.7%
Profit margin Net profit margin. Shows the overall profitability of the company. 32.3% 26.6% 20.8% -3.9% 13.4% 5.0%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 34.1% 31.5% 22.0% -3.8% 13.6% 5.5%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.2 0.9 0.7 0.4 0.4 0.8
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 10,073 54,967 44,474 32,687 19,269 46,087

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Komersantas - Social security debts

From To Debt, €
2026-08-26 2026-09-02 43.69
2026-08-23 2026-08-23 43.69
2026-08-19 2026-08-19 43.69
2026-01-22 2026-02-01 2.88
2026-01-01 2026-01-01 0.41
2025-12-19 2025-12-30 0.41
2025-12-16 2025-12-18 780.34
2025-12-01 2025-12-15 0.41
2025-11-27 2025-11-27 0.41
2025-11-18 2025-11-26 796.13
2025-10-23 2025-11-17 0.41
2025-09-16 2025-09-16 779.93
2025-07-16 2025-07-29 0.70
2025-02-10 2025-02-10 0.70
2025-01-16 2025-01-28 0.70
2024-10-16 2024-11-03 0.70
2024-09-17 2024-10-02 0.70
2024-08-19 2024-09-02 0.70
2024-07-24 2024-08-05 0.70
2024-07-16 2024-07-23 0.54
2024-06-18 2024-07-01 34.52
2024-05-16 2024-06-17 0.54
2024-04-23 2024-05-08 0.54
2024-03-18 2024-04-03 35.03
2024-03-04 2024-03-17 1.05
2024-02-19 2024-03-03 35.03
2024-01-24 2024-02-18 1.05
2024-01-23 2024-01-23 59.29
2024-01-16 2024-01-22 58.72
2024-01-15 2024-01-15 29.60
2023-12-18 2024-01-11 29.60
2023-11-16 2023-12-17 0.48
2023-10-25 2023-11-07 0.48
2023-10-17 2023-10-19 258.97
2023-09-18 2023-09-18 410.17
2022-01-18 2022-01-27 0.42
2021-12-16 2021-12-29 0.42
2021-11-16 2021-11-22 0.11
2021-10-18 2021-11-02 0.11
2021-09-16 2021-10-03 0.11

Komersantas - VMI tax arrears

From To Overdue, €
2026-06-30 2026-06-30 90.3
2026-06-18 2026-06-29 90.38
2026-02-21 2026-02-21 0.94
2025-10-30 2025-11-02 17.0
2025-10-24 2025-10-29 5.0
2025-10-08 2025-10-18 54.0
2025-09-16 2025-09-17 336.82
2025-09-12 2025-09-15 334.38
2025-08-19 2025-08-25 0.68

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Komersantas, UAB (code 305444001) is a Private Limited Liability Company engaged in retail sale of pharmaceutical products. In the latest financial year, 2025, the company generated revenue of €80.7K and net profit of €4.1K, corresponding to a profit margin of 5.0%. Revenue increased sharply by 318.6% year on year in 2025 and was 48.0% above the 2023 level, showing a clear recovery after the weaker 2024 result. The revenue trajectory moved from €54.5K in 2023 to €19.3K in 2024, before rebounding in 2025. Profitability followed a similar path, from a net loss of €2.1K in 2023 to a profit of €2.6K in 2024 and €4.1K in 2025. At year-end 2025, total assets stood at €94.9K, equity at €52.7K and liabilities at €42.2K. Key ratios indicate a moderate balance sheet and efficient use of assets, with ROE at 7.7%, ROA at 4.3%, debt-to-equity at 0.80 and asset turnover at 0.85x. Revenue per employee was €80.7K in 2025.